rolistobart   Click here for help

GtoPdb Ligand ID: 14652

Compound class: Antibody
Comment: Rolistobart is an anti-leukocyte immunoglobulin like receptor B4 (LILRB4) monoclonal antibody. It is proposed as an immunotherapeutic that is designed to disrupt the immunosuppressive LILRB4 checkpoint, and to restore anti-tumour immunity. Peptide sequences for the heavy and light chains of the antibody are claimed in Merck patent US11111297B2, with the humanized antibody referred to as mAb 46 (52B8 VH1 M64V/VL5 N34Q IgG4 S228P/Kappa) [1]. Rolistobart is likely intended as the INN for MK-0482.
Click here for help
Classification Click here for help
Compound class Antibody
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1427
Other databases
GtoPdb PubChem SID 530846900